MDCKS-MG Cell Line Suspension Culture Protein-Free Medium
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional MDCK cell lines require animal sera for culture, leading to high expenses and tumorigenicity, and result in viral antigenic variations and egg protein contamination, making them unsuitable for mass production and use in individuals allergic to egg proteins.
Innovation Solution
Development of a novel MDCK-derived cell line, MDCKS-MG, capable of suspension culture in a protein-free medium, which reduces tumorigenicity and viral antigenic variations, allowing for high and uniform virus productivity without egg protein contamination.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional MDCK cell lines are used for virus proliferation, then virus production can be achieved, but animal sera are required for culture leading to high expenses and tumorigenicity
Solution Approach 1:
The patent applies parameter changes by modifying the culture medium composition from animal sera-containing to protein-free medium, and changing the cell culture mode from adherent to suspension culture. These parameter changes enable virus production while eliminating tumorigenicity and reducing costs.
Solution Approach 2:
The invention extracts and eliminates the harmful animal sera components from the culture medium, replacing them with a protein-free formulation. This removal of harmful substances maintains virus production capability while eliminating tumorigenicity.
2Productivity
If fertilized eggs are used for influenza vaccine production, then vaccine can be produced, but egg proteins cannot be completely eliminated rendering the vaccine unsuitable for inoculation to persons allergic to egg proteins
Solution Approach 1:
The invention completely removes egg proteins from the vaccine production system by using MDCKS-MG cells cultured in protein-free medium instead of fertilized eggs. This extraction of harmful egg proteins makes the vaccine suitable for persons with egg allergies while maintaining productivity.
Solution Approach 2:
The patent uses MDCKS-MG cells as an alternative substrate that copies the necessary biological functions for virus proliferation without containing egg proteins. This cellular copy enables vaccine production free from egg protein contamination.
3Reliability
If adherent MDCK cell lines are used, then cell culture can be maintained, but much space is required for mass production thereby necessitating high expenses
Solution Approach 1:
The invention inverts the conventional adherent culture approach by adopting suspension culture mode. This inversion allows cells to grow in three-dimensional space rather than requiring flat surface area, dramatically reducing the space needed for mass production while maintaining cell culture reliability.
4Productivity
If conventional MDCK cell lines are used, then virus can be proliferated, but viral antigenic variations occur
Solution Approach 1:
The patent applies parameter changes by using MDCKS-MG cells with modified characteristics that provide greater stability. The suspension-adapted cells in protein-free medium create a more controlled environment that reduces viral antigenic variations while maintaining high virus proliferation capability.
Data Source
AI summary
The present invention relates to a novel MDCK-derived cell line capable of being suspension-cultured in a protein-free medium and a method for proliferating a virus using the MDCK-derived cell line to produce a vaccine. The novel MDCK-derived cell line exhibits high and uniform productivity for various viruses, while causing less viral antigenic variations with low tumorigenicity, and thus can be useful in producing viruses used for vaccines.